SCHEMBL1634271

SCHEMBL1634271

NS(=O)(=O)c1ccc(Nc2ncc3cccc(OCC(=O)N4CCOCC4)c3n2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK10 P53779 1/20 0.48
JAK3 P52333 4/20 0.48
BTK Q06187 4/20 0.48
PTK2 Q05397 2/20 0.47
CA12 O43570 3/20 0.47
CA1 P00915 3/20 0.47
CA2 P00918 3/20 0.47
CA9 Q16790 3/20 0.47
EGFR P00533 4/20 0.47
JAK2 O60674 2/20 0.46
FLT3 P36888 1/20 0.46
ITK Q08881 1/20 0.45
NUAK1 O60285 1/20 0.45
STK16 O75716 1/20 0.45
NTRK1 P04629 1/20 0.45
CSF1R P07333 1/20 0.45
CSNK2A2 P19784 1/20 0.45
TYK2 P29597 1/20 0.45
AAK1 Q2M2I8 1/20 0.45
ULK3 Q6PHR2 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12724751 0.84 CA1 (0.53) JAK3PTK2CA12CA1CA2
SCHEMBL1634662 0.82 MAPK10 (0.56) MAPK10JAK3CA12CA1CA2
SCHEMBL4007742 0.79 EGFR (0.59) JAK3BTKPTK2EGFRJAK2
SCHEMBL1632397 0.78 TBK1 (0.57) MAPK10JAK3PTK2CA12CA1
SCHEMBL1633433 0.76 MAPK10 (0.64) MAPK10JAK3CA12CA1CA2
SCHEMBL4007075 0.75 EGFR (0.65) JAK3BTKPTK2EGFRJAK2
SCHEMBL1634712 0.75 JAK2 (0.72) JAK3CA1CA2EGFRJAK2
SCHEMBL1634316 0.75 TBK1 (0.57) MAPK10JAK3PTK2CA12CA1
SCHEMBL1633872 0.75 CDK2 (0.52) JAK3PTK2CA12CA1CA2
SCHEMBL1634688 0.74 RXFP1 (0.45) JAK3BTKPTK2CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed